Philadelphia Rx Fraud Investigations Have New Chief; Are SEC Cases Next?

The Philadelphia U.S. Attorney's selection of Virginia Gibson to succeed Jim Sheehan as its Civil Division chief suggests continuity in the office's prescription drug fraud and kickback investigations